TickerFacts.

Volitionrx Ltd (VNRX): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2018-12-31, 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$89.6K
Year ended 2025-12-31
$22.0K
Trailing 12 months to 2026-06-30
-61.5%
3-year compound annual growth
-45.9%
5-year compound annual growth
$1.94M2011-12-31: $34.9K2012-12-31: $90.7K2013-12-31: $7142014-12-31: $303.0K2015-12-31: $77.2K2016-12-31: $415.1K2017-12-31: $1.43M2018-12-31: -$301.8K2019-12-31: $511.3K2020-12-31: $1.94M2021-12-31: $973.6K2022-12-31: $1.57M2023-12-31: $1.08M2024-12-31: $277.5K2025-12-31: $89.6K$89.6K
2011-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$89.6K-67.7%2026-03-31, From 2025-01-01
2024-12-31$277.5K-74.4%2026-03-31, From 2024-01-01
2023-12-31$1.08M-31.0%2025-03-31, From 2023-01-01
2022-12-31$1.57M+61.3%2024-03-25, From 2022-01-01
2021-12-31$973.6K-49.8%2023-03-15, From 2021-01-01
2020-12-31$1.94M+279.7%2022-03-30, From 2020-01-01
2019-12-31$511.3Kn/c2021-03-22, From 2019-01-01
2018-12-31-$301.8Kn/c2020-02-20, From 2018-01-01
2017-12-31$1.43M+243.4%2019-03-13, From 2017-01-01
2016-12-31$415.1K+437.7%2018-03-01, From 2016-01-01
2015-12-31$77.2K-74.5%2017-03-10, From 2015-01-01
2014-12-31$303.0Kn/m2016-03-11, From 2014-01-01
2013-12-31$714-99.2%2015-03-18, From 2013-01-01
2012-12-31$90.7K+160.1%2014-03-28, From 2012-01-01
2011-12-31$34.9Kn/a2013-04-01, From 2011-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Volitionrx Ltd (VNRX)2025-12-31$89.6K-67.7%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$2.71M+41.4%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$3.19M+517.2%
Aspira Women's Health Inc. (AWHL)2025-12-31$16.0K-56.8%
Immucell Corp (ICCC)2025-12-31$1.25M+168.5%
Alpha Teknova, Inc. (TKNO)2025-12-31$1.15M+2.0%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$1.13M-80.5%
Cardio Diagnostics Holdings, Inc. (CDIO)2025-12-31$187.3K-12.8%
Neogen Corp (NEOG)2026-05-31$51.30M-51.0%

Compare VNRX, CLDX, IMDX, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗